These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 16397057)

  • 1. Celecoxib decreases Ki-67 proliferative index in active smokers.
    Mao JT; Fishbein MC; Adams B; Roth MD; Goodglick L; Hong L; Burdick M; Strieter ER; Holmes C; Tashkin DP; Dubinett SM
    Clin Cancer Res; 2006 Jan; 12(1):314-20. PubMed ID: 16397057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Celecoxib modulates the expression of cyclooxygenase-2, ki67, apoptosis-related marker, and microvessel density in human cervical cancer: a pilot study.
    Ferrandina G; Ranelletti FO; Legge F; Lauriola L; Salutari V; Gessi M; Testa AC; Werner U; Navarra P; Tringali G; Battaglia A; Scambia G
    Clin Cancer Res; 2003 Oct; 9(12):4324-31. PubMed ID: 14555502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Celecoxib modulates the capacity for prostaglandin E2 and interleukin-10 production in alveolar macrophages from active smokers.
    Mao JT; Roth MD; Serio KJ; Baratelli F; Zhu L; Holmes EC; Strieter RM; Dubinett SM
    Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5835-41. PubMed ID: 14676104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lung cancer chemoprevention with celecoxib in former smokers.
    Mao JT; Roth MD; Fishbein MC; Aberle DR; Zhang ZF; Rao JY; Tashkin DP; Goodglick L; Holmes EC; Cameron RB; Dubinett SM; Elashoff R; Szabo E; Elashoff D
    Cancer Prev Res (Phila); 2011 Jul; 4(7):984-93. PubMed ID: 21733822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pilot randomized phase II study of celecoxib in oral premalignant lesions.
    Papadimitrakopoulou VA; William WN; Dannenberg AJ; Lippman SM; Lee JJ; Ondrey FG; Peterson DE; Feng L; Atwell A; El-Naggar AK; Nathan CO; Helman JI; Du B; Yueh B; Boyle JO
    Clin Cancer Res; 2008 Apr; 14(7):2095-101. PubMed ID: 18381950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neoadjuvant therapy with celecoxib to women with early stage breast cancer.
    Tfayli A; Yang J; Kojouri K; Kesserwan C; Jafari M; Ozer H
    Neoplasma; 2008; 55(2):122-6. PubMed ID: 18237249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pilot surrogate endpoint biomarker study of celecoxib in oral premalignant lesions.
    Wirth LJ; Krane JF; Li Y; Othus M; Moran AE; Dorfman DM; Norris CM; Goguen L; Posner MR; Haddad RI; Bertagnolli MM
    Cancer Prev Res (Phila); 2008 Oct; 1(5):339-48. PubMed ID: 19138978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell proliferation and apoptotic indices predict adenoma regression in a placebo-controlled trial of celecoxib in familial adenomatous polyposis patients.
    Sinicrope FA; Half E; Morris JS; Lynch PM; Morrow JD; Levin B; Hawk ET; Cohen DS; Ayers GD; Stephens LC;
    Cancer Epidemiol Biomarkers Prev; 2004 Jun; 13(6):920-7. PubMed ID: 15184247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bronchial epithelial Ki-67 index is related to histology, smoking, and gender, but not lung cancer or chronic obstructive pulmonary disease.
    Miller YE; Blatchford P; Hyun DS; Keith RL; Kennedy TC; Wolf H; Byers T; Bunn PA; Lewis MT; Franklin WA; Hirsch FR; Kittelson J
    Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2425-31. PubMed ID: 18006932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of pulmonary leukotriene B4 production by cyclooxygenase-2 inhibitors and lipopolysaccharide.
    Mao JT; Tsu IH; Dubinett SM; Adams B; Sarafian T; Baratelli F; Roth MD; Serio KJ
    Clin Cancer Res; 2004 Oct; 10(20):6872-8. PubMed ID: 15501964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. More pronounced inhibition of cyclooxygenase 2, increase in blood pressure, and reduction of heart rate by treatment with diclofenac compared with celecoxib and rofecoxib.
    Hinz B; Dormann H; Brune K
    Arthritis Rheum; 2006 Jan; 54(1):282-91. PubMed ID: 16385545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of a selective cyclooxygenase-2 inhibitor on endometrial epithelial cells from patients with endometriosis.
    Olivares C; Bilotas M; Buquet R; Borghi M; Sueldo C; Tesone M; Meresman G
    Hum Reprod; 2008 Dec; 23(12):2701-8. PubMed ID: 18716040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prophylactic effect of a selective COX-2 inhibitor celecoxib on carcinogen-induced gastric premalignant lesions in rats].
    Tang BD; Zeng ZR; Hu PJ
    Ai Zheng; 2006 Oct; 25(10):1205-9. PubMed ID: 17059761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. E2F1 overexpression correlates with thymidylate synthase and survivin gene expressions and tumor proliferation in non small-cell lung cancer.
    Huang CL; Liu D; Nakano J; Yokomise H; Ueno M; Kadota K; Wada H
    Clin Cancer Res; 2007 Dec; 13(23):6938-46. PubMed ID: 18056168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of glioblastoma radioresponse by a selective COX-2 inhibitor celecoxib: inhibition of tumor angiogenesis with extensive tumor necrosis.
    Kang KB; Wang TT; Woon CT; Cheah ES; Moore XL; Zhu C; Wong MC
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):888-96. PubMed ID: 17293239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COX-2 inhibitor, celecoxib, may prevent lung cancer.
    Oncology (Williston Park); 2011 Aug; 25(9):848-9. PubMed ID: 21936449
    [No Abstract]   [Full Text] [Related]  

  • 17. A randomized controlled trial investigating the effects of celecoxib in patients with localized prostate cancer.
    Sooriakumaran P; Coley HM; Fox SB; Macanas-Pirard P; Lovell DP; Henderson A; Eden CG; Miller PD; Langley SE; Laing RW
    Anticancer Res; 2009 May; 29(5):1483-8. PubMed ID: 19443354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perioperative cyclooxygenase 2 inhibition to reduce tumor cell adhesion and metastatic potential of circulating tumor cells in non-small cell lung cancer.
    Backhus LM; Sievers E; Lin GY; Castanos R; Bart RD; Starnes VA; Bremner RM
    J Thorac Cardiovasc Surg; 2006 Aug; 132(2):297-303. PubMed ID: 16872953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective cyclooxygenase-2 inhibition with celecoxib decreases angiotensin II-induced abdominal aortic aneurysm formation in mice.
    King VL; Trivedi DB; Gitlin JM; Loftin CD
    Arterioscler Thromb Vasc Biol; 2006 May; 26(5):1137-43. PubMed ID: 16514081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Celecoxib inhibits meningioma tumor growth in a mouse xenograft model.
    Ragel BT; Jensen RL; Gillespie DL; Prescott SM; Couldwell WT
    Cancer; 2007 Feb; 109(3):588-97. PubMed ID: 17177201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.